240 related articles for article (PubMed ID: 33176810)
1. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
Munkholm L; Rubin O
Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
[TBL] [Abstract][Full Text] [Related]
2. National action plans on antimicrobial resistance in Latin America: an analysis via a governance framework.
Avello P; Collins LM; Gómez SA; Luna F; Fernández Miyakawa ME; West HM; Iossa G
Health Policy Plan; 2024 Feb; 39(2):188-197. PubMed ID: 38179856
[TBL] [Abstract][Full Text] [Related]
3. Attention to the Tripartite's one health measures in national action plans on antimicrobial resistance.
Munkholm L; Rubin O; Bækkeskov E; Humboldt-Dachroeden S
J Public Health Policy; 2021 Jun; 42(2):236-248. PubMed ID: 33597731
[TBL] [Abstract][Full Text] [Related]
4. Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.
Patel J; Harant A; Fernandes G; Mwamelo AJ; Hein W; Dekker D; Sridhar D
Lancet Infect Dis; 2023 Jun; 23(6):706-718. PubMed ID: 36657475
[TBL] [Abstract][Full Text] [Related]
5. A review of national action plans on antimicrobial resistance: strengths and weaknesses.
Willemsen A; Reid S; Assefa Y
Antimicrob Resist Infect Control; 2022 Jun; 11(1):90. PubMed ID: 35739564
[TBL] [Abstract][Full Text] [Related]
6. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.
Charani E; Mendelson M; Pallett SJC; Ahmad R; Mpundu M; Mbamalu O; Bonaconsa C; Nampoothiri V; Singh S; Peiffer-Smadja N; Anton-Vazquez V; Moore LSP; Schouten J; Kostyanev T; Vlahović-Palčevski V; Kofteridis D; Corrêa JS; Holmes AH
Lancet Glob Health; 2023 Mar; 11(3):e466-e474. PubMed ID: 36739875
[TBL] [Abstract][Full Text] [Related]
7. A comparative assessment of action plans on antimicrobial resistance from OECD and G20 countries using natural language processing.
Özçelik EA; Doucet C; Kang H; Levy N; Feldhaus I; Hashiguchi TCO; Lerouge A; Cecchini M
Health Policy; 2022 Jun; 126(6):522-533. PubMed ID: 35379524
[TBL] [Abstract][Full Text] [Related]
8. Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies.
Samuel F Orubu E; Sutradhar I; Zaman MH; Wirtz VJ
J Glob Health; 2020 Dec; 10(2):020414. PubMed ID: 33110576
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review.
van Heuvel L; Caini S; Dückers MLA; Paget J
Global Health; 2022 Oct; 18(1):85. PubMed ID: 36253789
[TBL] [Abstract][Full Text] [Related]
10. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
Harant A
Antimicrob Resist Infect Control; 2022 Jan; 11(1):15. PubMed ID: 35073967
[TBL] [Abstract][Full Text] [Related]
11. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
[TBL] [Abstract][Full Text] [Related]
12. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach.
Chua AQ; Verma M; Hsu LY; Legido-Quigley H
Lancet Reg Health West Pac; 2021 Feb; 7():100084. PubMed ID: 34327414
[TBL] [Abstract][Full Text] [Related]
13. The best laid plans?: international governance perspectives in AMR national action plans in Europe.
Carelli DE; Mitsouli ET; Ogne JB; Pierre J
Eur J Public Health; 2023 Aug; 33(4):682-686. PubMed ID: 37196335
[TBL] [Abstract][Full Text] [Related]
14. Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.
Allel K; Fernandez-Miyakawa M; Gaze W; Petroni A; Corso A; Luna F; Barcelona L; Boden L; Pitchforth E;
BMJ Open; 2024 Jun; 14(6):e082156. PubMed ID: 38889938
[TBL] [Abstract][Full Text] [Related]
15. A Qualitative Study on the Design and Implementation of the National Action Plan on Antimicrobial Resistance in the Philippines.
Lota MMM; Chua AQ; Azupardo K; Lumangaya C; Reyes KAV; Villanueva SYAM; Legido-Quigley H; Roxas EA
Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740226
[TBL] [Abstract][Full Text] [Related]
16. Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana's success story.
Opintan JA
Afr J Lab Med; 2018; 7(2):825. PubMed ID: 30568905
[TBL] [Abstract][Full Text] [Related]
17. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African region: A roadmap for action.
Iwu CD; Patrick SM
Int J Antimicrob Agents; 2021 Oct; 58(4):106411. PubMed ID: 34371112
[TBL] [Abstract][Full Text] [Related]
18. Monitoring progress on Antimicrobial Resistance (AMR) response in the World Health Organization African region: Insights from the Tracking AMR Country Self-Assessment Survey (TrACSS) 2021 results for the human health sector.
Gahimbare L; Mwamelo AJ; Yahya AA; Fuller W; Padiyara P; Prakash P; Balachandran A; Makubalo EL
J Public Health Afr; 2023 Nov; 14(11):2392. PubMed ID: 38500695
[TBL] [Abstract][Full Text] [Related]
19. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
